(US)
Need an official quote in your mailbox?
Our automated system will send you a quote for your specific qty along with Discount, timelines and Stock status.
Bis(2-(dicyclohexylphosphino)ethyl)amine
CATALYSTS
| CAT No.# | CS-BN-00004 |
| Category | Catalysts |
| CAS | 550373-32-5 |
| Stock Status |
AVAILABLE
Do you want a quotation or have a question about 'Bis(2-(dicyclohexylphosphino)ethyl)amine' ? We normally respond within 2 hours.Do you want a quotation or have a question about 'Bis(2-(dicyclohexylphosphino)ethyl)amine' ? We normally respond within 2 hours.(Available within 3-5 days) Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing. |
| Molecular Weight | 465.67 |
| Molecular Formula | C28H53NP2 |
| Synonyms: | bis[2-(dicyclohexylphosphanyl)ethyl]amine |
| Shipping: | Free Shipping for worldwide on order above 2000 USD |
Product rating: 9 Bis(2-(dicyclohexylphosphino)ethyl)amine based on 20 ratings
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Palbociclib N-Glucuronide
15. Carpropamid
16. Olmesartan N1-Trityl Impurity
17. 1-Octadecanethiol
18. H-Ser(Bzl)-OBzl · p-tosylate (E-3755.0005)
19. 2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene
20. α-Pinene oxide
This page contains information about Bis(2-(dicyclohexylphosphino)ethyl)amine Cas 550373-32-5 and its Catalysts.
Bis(2-(dicyclohexylphosphino)ethyl)amine Bis(2-(dicyclohexylphosphino)ethyl)amine Worldwide Suppliers of Bis(2-(dicyclohexylphosphino)ethyl)amine https://www.clearsynth.com/en/CSBN00004.html Catalysts Clearsynth 550373-32-5
"Products currently covered by valid US Patents
are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at
buyer risk."